Form 8.3 - Udg Healthcare Plc

 
TIDMUDG 
 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

   1.    KEY INFORMATION 
 
Name of person dealing      Elliott Investment Management, 
 (Note 1)                    L.P 
                             Elliott International, 
                             L.P. 
                             Elliott Associates, L.P. 
--------------------------  ------------------------------ 
Company dealt in            UDG Healthcare plc 
--------------------------  ------------------------------ 
Class of relevant security  Ordinary Shares: IE0033024807 
 to which the dealings 
 being disclosed relate 
 (Note 2) 
--------------------------  ------------------------------ 
Date of dealing             17(th) June 2021 
--------------------------  ------------------------------ 
 
 
   2.    INTERESTS AND SHORT POSITIONS 
   (a)    Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) 
 
                                        Long             Short 
---------------------------  --------------------  ------------- 
                             Number        (%)     Number    (%) 
---------------------------  ------------  ------  --------  --- 
(1) Relevant securities 
---------------------------  --------------------  ------------- 
(2) Derivatives (other 
 than options)                 9,376,740 (3.722%) 
---------------------------  --------------------  ------------- 
(3) Options and agreements 
 to purchase/sell 
---------------------------  --------------------  ------------- 
Total                          9,376,740 (3.722%) 
---------------------------  --------------------  ------------- 
 
   (b)    Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) 
 
Class of relevant security:          Long          Short 
---------------------------  --------------  --------------- 
                             Number     (%)  Number      (%) 
---------------------------  -------    ---  --------    --- 
(1) Relevant securities 
---------------------------  --------------  --------------- 
 
 (2) Derivatives (other 
 than options) 
---------------------------  --------------  --------------- 
 
 (3) Options and agreements 
 to purchase/sell 
---------------------------  --------------  --------------- 
Total 
---------------------------  --------------  --------------- 
 

Ap20

   1.    DEALINGS (Note 4) 
   (a)    Purchases and sales 
 
 
 Purchase/sale   Number of relevant securities   Price per unit 
                                                 (Note 5) 
--------------  ------------------------------  --------------- 
 
 
   (b)    Derivatives transactions (other than options transactions) 
 
Product      Nature of transaction  Number of relevant  Price per 
 name,        (Note 6)               securities          unit 
 e.g. CFD                            (Note 7)            (Note 5) 
-----------  ---------------------  ------------------  ----------- 
Equity Swap  Increased Long         666,141             GBP10.47425 
-----------  ---------------------  ------------------  ----------- 
 
   (c)    Options transactions in respect of existing relevant securities 
   (i)    Writing, selling, purchasing or varying 
 
Product     Writing,      Number of       Exercise  Type,            Expiry  Option 
 name,       selling,      securities      price     e.g. American,   date    money paid/received 
 e.g. call   purchasing,   to which                  European                 per unit 
 option      varying       the option                etc.                     (Note 5) 
             etc.          relates (Note 
                           7) 
----------  ------------  --------------  --------  ---------------  ------  -------------------- 
 
 
   (ii)    Exercising 
 
Product name,            Number of securities      Exercise price 
 e.g. call option                                   per unit (Note 
                                                    5) 
-----------------  --------------------------  ------------------- 
 
 
   (d)    Other dealings (including transactions in respect of new securities) (Note 4) 
 
Nature of transaction        Details      Price per unit 
 (Note 8)                                  (if applicable) 
                                           (Note 5) 
---------------------  -------------  -------------------- 
 
 

Ap21

   2.    OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 attached? (Note 9) YES/NO

 
Date of disclosure           18/06/2021 
---------------------------  ----------------------------- 
Contact name                 Michael Cross 
---------------------------  ----------------------------- 
Telephone number             0203 009 1306 
                              [e-mail] 
---------------------------  ----------------------------- 
If a connected EFM, name 
 of offeree/offeror with 
 which connected 
---------------------------  ----------------------------- 
If a connected EFM, state 
 nature of connection (Note 
 10) 
---------------------------  ----------------------------- 
 

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

 
  Product       Written,       Number of relevant     Exercise  Type, e.g.  Expiry 
   name,         or purchased   securities             price     American,   date 
   e.g. call                    to which the           (Note     European 
   option                       option or derivative   2)        etc. 
                                relates 
------------  ---------------  ---------------------  --------  ----------  ------ 
 
 
 
 

Notes

   1. Where there are open option positions or open derivative positions 
      (except for CFDs), full details should be given. Full details of any 
      existing agreements to purchase or to sell must also be given on this 
      form. 
 
   2. For all prices and other monetary amounts, the currency must be stated. 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

(END) Dow Jones Newswires

June 18, 2021 10:25 ET (14:25 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.